Results for "consumer data right"
681-690 of 852 results for 'consumer data right'
Retail banking and responsible lending during COVID-19
The sudden and unknown nature of COVID-19 has triggered a global economic shock, and disrupted Australia's economy. As we enter a national state of economic 'hibernation', banks and lenders are grappling with a sudden influx of relief requests from consumer and business customers. ...
A snapshot of ESG in Vietnam
Environmental, Social and Governance issues continue to create a paradigm shift in the way businesses are run.2022 looks to be another big year in the space, with those slow to adapt getting left behind. We break down key ESG trends to watch for in 2022. ...
Regulatory scrutiny of private capital increases
Private capital is becoming a growing focus of regulators, both in Australia and internationally, given the ever-increasing flow of capital to the sector in recent years. ...
Allens advises IAG on $1.35bn strategic alliance with RAC WA
The partnership sees IAG acquire the RAC WA Insurance business and enter into a 20-year exclusive distribution agreement for RAC-branded home, motor and niche insurance products. 'We are delighted ...
Summary of proposed reforms to FIRB regime – Tranche 2 Regulations
On 18 September 2020 the Federal Government released exposure drafts of the 'Tranche 2 Regulations' to amend Australia's foreign investment laws. This follows the release on 31 July 2020 of the 'Tranc ...
Australia's foreign investment regime - regulatory burden reduced
Significant changes to Australias foreign investment regime came into effect on 1 July 2017 intended to address concerns regarding this regime raised since its introduction in December 2015 The amendments reduce the regulatory burden in a number of key ways and will impact a range of foreign ...
Australia's foreign investment regime - Budget changes
The Australian Government flagged a number of changes to Australias foreign investment regime in the 2017 Budget In a welcome development the changes seek to simplify an otherwise complex regime and encourage foreign investment in Australia Partner Wendy Rae and Associate Nick Kefalianos examine the ...
Patent term extensions under siege: a new era of challenges for pharmaceutical patentees
A recent Federal Court decision has struck down a patent term extension granted to Novartis for its blockbuster heart failure drug Entresto. The decision in Novartis AG v Pharmacor Pty Limited follows a recent trend of successful challenges by generic pharmaceutical companies. ...
Major new proposals for regulating personalised medical devices
Proposed amendments to the regulation of personalised medical devices, which introduce a set of new internationally haromised definitions will have a significant impact on the industry ...